Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain
Recruiting
N/A
Interventional Study
Seroma Following Procedure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 134 (estimated)
- Sponsor
- Omphis Foundation · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Axillary lymphadenectomy in breast cancer continues to be a common practice in certain patients. The use of sealants and drains continues to be a source of disagreement among the scientific community. That is why the study was designed to show whether the sealant reduces seroma after axillary lymphadenectomy without drainage.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Over 18 years old
* Conservative surgery for breast cancer with associated axillary lymphadenectomy
Exclusion Criteria:
* Mastectomy
* History of axillary surgery or ipsilateral axillary radiotherapy
* ASA 4 patients. (ASA 3 patients selected)
* Lack of adequate cognitive ca…
Contacts